US Stock MarketDetailed Quotes

OCUP Ocuphire Pharma

Watchlist
  • 1.535
  • +0.005+0.33%
Close Apr 25 16:00 ET
  • 1.560
  • +0.025+1.63%
Post 19:30 ET
38.09MMarket Cap-3336P/E (TTM)

Ocuphire Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
-52.20%19.05M
-95.76%1.69M
11.94M
3.67M
1.75M
6,665.70%39.85M
39.85M
0
0
0
Operating revenue
-52.20%19.05M
-95.76%1.69M
--11.94M
--3.67M
--1.75M
6,665.70%39.85M
--39.85M
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
36.94%29.61M
26.24%7.12M
22.28%5.55M
83.54%9.06M
21.08%7.88M
-7.17%21.62M
-8.29%5.64M
-3.88%4.54M
-31.77%4.94M
25.49%6.51M
Selling and administrative expenses
64.52%11.96M
59.64%3.28M
20.67%2.06M
144.37%4.34M
31.62%2.29M
-10.49%7.27M
45.26%2.05M
6.77%1.7M
-47.89%1.78M
1.88%1.74M
-General and administrative expense
64.52%11.96M
----
----
----
----
--7.27M
----
----
----
----
Research and development costs
22.97%17.65M
7.11%3.84M
23.25%3.49M
49.37%4.72M
17.25%5.6M
-5.39%14.36M
-24.28%3.59M
-9.31%2.84M
-17.42%3.16M
37.05%4.77M
Operating profit
-157.96%-10.56M
-115.87%-5.43M
240.72%6.39M
-9.13%-5.39M
5.79%-6.13M
180.27%18.23M
656.26%34.21M
-7.23%-4.54M
30.81%-4.94M
-25.49%-6.51M
Net non-operating interest income expense
-14,655.56%-1.33M
0
-1.33M
0
0
-350.00%-9K
0
0
-4K
-5K
Non-operating interest expense
--0
--0
--0
--0
--0
350.00%9K
--0
--0
--4K
--5K
Total other finance cost
--1.33M
--0
--1.33M
----
----
----
----
----
----
----
Other net income (expense)
13,792.86%1.92M
1,273.91%632K
7,285.71%517K
2,753.33%428K
514.63%340K
99.96%-14K
128.57%46K
250.00%7K
1,400.00%15K
99.76%-82K
Gain on sale of security
--80K
--19K
--61K
----
----
----
----
----
----
----
Other non- operating income (expenses)
13,221.43%1.84M
1,232.61%613K
6,414.29%456K
2,753.33%428K
514.63%340K
91.08%-14K
128.57%46K
250.00%7K
1,400.00%15K
-8,300.00%-82K
Income before tax
-154.79%-9.97M
-114.00%-4.8M
223.04%5.58M
-0.69%-4.96M
12.19%-5.79M
132.11%18.2M
642.63%34.26M
-7.12%-4.53M
30.96%-4.93M
83.10%-6.6M
Income tax
-96.19%12K
-100.63%-2K
14K
0
0
315K
315K
0
0
0
Net income
-155.83%-9.99M
-114.13%-4.8M
222.73%5.56M
-0.69%-4.96M
12.19%-5.79M
131.55%17.89M
637.64%33.94M
-7.12%-4.53M
30.96%-4.93M
83.10%-6.6M
Net income continuous Operations
-155.83%-9.99M
-114.13%-4.8M
222.73%5.56M
-0.69%-4.96M
12.19%-5.79M
131.55%17.89M
637.64%33.94M
-7.12%-4.53M
30.96%-4.93M
83.10%-6.6M
Minority interest income
Net income attributable to the parent company
-155.83%-9.99M
-114.13%-4.8M
222.73%5.56M
-0.69%-4.96M
12.19%-5.79M
131.55%17.89M
637.64%33.94M
-7.12%-4.53M
30.96%-4.93M
83.10%-6.6M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-155.83%-9.99M
-114.13%-4.8M
222.73%5.56M
-0.69%-4.96M
12.19%-5.79M
131.55%17.89M
637.64%33.94M
-7.12%-4.53M
30.96%-4.93M
83.10%-6.6M
Basic earnings per share
-151.11%-0.46
-112.88%-0.21
218.18%0.26
4.00%-0.24
20.00%-0.28
123.56%0.9
565.71%1.63
12.00%-0.22
51.92%-0.25
90.20%-0.35
Diluted earnings per share
-152.87%-0.46
-113.29%-0.21
213.64%0.25
4.00%-0.24
20.00%-0.28
122.77%0.87
551.43%1.58
12.00%-0.22
51.92%-0.25
90.20%-0.35
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue -52.20%19.05M-95.76%1.69M11.94M3.67M1.75M6,665.70%39.85M39.85M000
Operating revenue -52.20%19.05M-95.76%1.69M--11.94M--3.67M--1.75M6,665.70%39.85M--39.85M--0--0--0
Cost of revenue
Gross profit
Operating expense 36.94%29.61M26.24%7.12M22.28%5.55M83.54%9.06M21.08%7.88M-7.17%21.62M-8.29%5.64M-3.88%4.54M-31.77%4.94M25.49%6.51M
Selling and administrative expenses 64.52%11.96M59.64%3.28M20.67%2.06M144.37%4.34M31.62%2.29M-10.49%7.27M45.26%2.05M6.77%1.7M-47.89%1.78M1.88%1.74M
-General and administrative expense 64.52%11.96M------------------7.27M----------------
Research and development costs 22.97%17.65M7.11%3.84M23.25%3.49M49.37%4.72M17.25%5.6M-5.39%14.36M-24.28%3.59M-9.31%2.84M-17.42%3.16M37.05%4.77M
Operating profit -157.96%-10.56M-115.87%-5.43M240.72%6.39M-9.13%-5.39M5.79%-6.13M180.27%18.23M656.26%34.21M-7.23%-4.54M30.81%-4.94M-25.49%-6.51M
Net non-operating interest income expense -14,655.56%-1.33M0-1.33M00-350.00%-9K00-4K-5K
Non-operating interest expense --0--0--0--0--0350.00%9K--0--0--4K--5K
Total other finance cost --1.33M--0--1.33M----------------------------
Other net income (expense) 13,792.86%1.92M1,273.91%632K7,285.71%517K2,753.33%428K514.63%340K99.96%-14K128.57%46K250.00%7K1,400.00%15K99.76%-82K
Gain on sale of security --80K--19K--61K----------------------------
Other non- operating income (expenses) 13,221.43%1.84M1,232.61%613K6,414.29%456K2,753.33%428K514.63%340K91.08%-14K128.57%46K250.00%7K1,400.00%15K-8,300.00%-82K
Income before tax -154.79%-9.97M-114.00%-4.8M223.04%5.58M-0.69%-4.96M12.19%-5.79M132.11%18.2M642.63%34.26M-7.12%-4.53M30.96%-4.93M83.10%-6.6M
Income tax -96.19%12K-100.63%-2K14K00315K315K000
Net income -155.83%-9.99M-114.13%-4.8M222.73%5.56M-0.69%-4.96M12.19%-5.79M131.55%17.89M637.64%33.94M-7.12%-4.53M30.96%-4.93M83.10%-6.6M
Net income continuous Operations -155.83%-9.99M-114.13%-4.8M222.73%5.56M-0.69%-4.96M12.19%-5.79M131.55%17.89M637.64%33.94M-7.12%-4.53M30.96%-4.93M83.10%-6.6M
Minority interest income
Net income attributable to the parent company -155.83%-9.99M-114.13%-4.8M222.73%5.56M-0.69%-4.96M12.19%-5.79M131.55%17.89M637.64%33.94M-7.12%-4.53M30.96%-4.93M83.10%-6.6M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -155.83%-9.99M-114.13%-4.8M222.73%5.56M-0.69%-4.96M12.19%-5.79M131.55%17.89M637.64%33.94M-7.12%-4.53M30.96%-4.93M83.10%-6.6M
Basic earnings per share -151.11%-0.46-112.88%-0.21218.18%0.264.00%-0.2420.00%-0.28123.56%0.9565.71%1.6312.00%-0.2251.92%-0.2590.20%-0.35
Diluted earnings per share -152.87%-0.46-113.29%-0.21213.64%0.254.00%-0.2420.00%-0.28122.77%0.87551.43%1.5812.00%-0.2251.92%-0.2590.20%-0.35
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg